Telmisartan targets Nrf2-HO1 axis in MASLD modulating oxidative stress, inflammation, and mitochondrial dysfunction: mechanistic insights

Sherif A. Kamar; Mohamed Ibrahim Attia; Hanadi A. Alahmadi; Alhamza Younis Hamza; Nevien Hendawy; Tarek Abd El-Galil; Tarek A. Yousef; Abdullah Al-Dakhil; Sara Khedr; Amal H. Eissa; Lamiaa M. Elabbasy; Yosra Magdy

doi:10.1080/19932820.2025.2585617

Citations

408

Views

Abstract not available for this publication.

Cite this Article (APA)

Sherif, A. K., Mohamed, I. A., Hanadi, A. A., Alhamza, Y. H., Nevien, H., Tarek, A. E., Tarek, A. Y., Abdullah, A., Sara, K., Amal, H. E., Lamiaa, M. E., Yosra, M. (2025). Telmisartan targets Nrf2-HO1 axis in MASLD modulating oxidative stress, inflammation, and mitochondrial dysfunction: mechanistic insights. Libyan Journal of Medicine. https://doi.org/10.1080/19932820.2025.2585617